A10BX03 • nateglinide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins
Nateglinide is an antidiabetic medication used to control blood sugar levels in patients with type 2 diabetes. It belongs to the meglitinide class and works by stimulating insulin secretion from the pancreas, particularly after meals.
The medication is taken orally, usually before meals, with the dose adjusted based on blood glucose levels. Common side effects include hypoglycemia, nausea, and weight gain.
Nateglinide is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or hypersensitivity to the active substance. It should also be used with caution in patients with hepatic or renal impairment.
This medication is an effective option for controlling postprandial blood sugar levels, helping to prevent complications associated with type 2 diabetes.
Substance: nateglinide
Date of last drug list: 01-07-2013
Commercial code: W51759005
Concentration: 180mg
Pharmaceutical form: film-coated tablets
Quantity: 360
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).